The role of miR‐34 in cancer drug resistance
Sanaz Naghizadeh(Tabriz University of Medical Sciences), Behzad Mansoori(The Wistar Institute)
Cited by 34
Related Papers
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancy
|Life Sciences|2021|52
HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
|Cancers|2021|34